[Ceftazidime in the treatment of pediatric infections--a review].

Suppr

超能文献

作者信息

Adam D, Tolxdorff-Neutzling R

机构信息

Abteilung für antimikrobielle Therapie und Infektionsimmunologie, München.

出版信息

Infection. 1987;15 Suppl 4:S202-8. doi: 10.1007/BF01645872.

DOI:10.1007/BF01645872

PMID:3312036

Abstract

摘要

相似文献

[Ceftazidime in the treatment of pediatric infections--a review].

Infection. 1987;15 Suppl 4:S202-8. doi: 10.1007/BF01645872.

[Experiences with ceftazidime in the therapy of neonatal infections].

Infection. 1987;15 Suppl 4:S209-13. doi: 10.1007/BF01645873.

Susceptibility of clinical isolates to cephalosporins.

Indian Pediatr. 1989 Sep;26(9):965-6.

Ceftazidime: summary of the first international symposium.

J Antimicrob Chemother. 1981 Sep;8 Suppl B:349-52. doi: 10.1093/jac/8.suppl_b.349.

[The pharmacokinetics of ceftazidime in newborn babies with suppurative septic diseases].

Pediatriia. 1991(6):48-50.

Ceftazidime (Fortaz).

Med Lett Drugs Ther. 1985 Oct 11;27(698):85-7.

[Ceftazidime and probabilistic treatment of severe infections in adults].

Presse Med. 1988 Oct 26;17(37):1981-4.

Relationship of ceftazidime pharmacokinetic indices with therapeutic outcome in patients with cystic fibrosis.

Pediatr Infect Dis J. 1993 Dec;12(12):997-1001. doi: 10.1097/00006454-199312000-00007.

[Empirical antibiotic therapy and ceftazidime].

Presse Med. 1988 Oct 26;17(37):1977-80.

[Ceftazidime in the treatment of severe bacterial infections].

Sb Lek. 1988 Nov;90(11-12):339-43.

本文引用的文献

Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa.

Antimicrob Agents Chemother. 1982 Jan;21(1):11-8. doi: 10.1128/AAC.21.1.11.

Pharmacokinetics of ceftazidime in newborn infants.

Antimicrob Agents Chemother. 1984 Oct;26(4):583-4. doi: 10.1128/AAC.26.4.583.

Ceftazidime as initial therapy for suspected bacterial infections in hospitalized pediatric patients.

Antimicrob Agents Chemother. 1984 Sep;26(3):318-21. doi: 10.1128/AAC.26.3.318.

Ceftazidime in the treatment of pediatric patients with severe urinary tract infections due to Pseudomonas spp.

Antimicrob Agents Chemother. 1984 Mar;25(3):395-7. doi: 10.1128/AAC.25.3.395.

Comparison of the concentrations of ceftazidime in the serum of newborn infants after intravenous and intramuscular administration.

Antimicrob Agents Chemother. 1983 Dec;24(6):955-6. doi: 10.1128/AAC.24.6.955.

Ceftazidime in the treatment of chronic suppurative otitis media in children.

J Antimicrob Chemother. 1983 Jul;12 Suppl A:365-7. doi: 10.1093/jac/12.suppl_a.365.

A preliminary pharmacokinetic study of ceftazidime in premature, new born and small infants.

J Antimicrob Chemother. 1983 Jul;12 Suppl A:361-4. doi: 10.1093/jac/12.suppl_a.361.

Ceftazidime in the treatment of febrile immunosuppressed children.

J Antimicrob Chemother. 1983 Jul;12 Suppl A:357-60. doi: 10.1093/jac/12.suppl_a.357.

Ceftazidime or gentamicin plus benzylpenicillin in neonates less than forty-eight hours old.

J Antimicrob Chemother. 1983 Jul;12 Suppl A:353-6. doi: 10.1093/jac/12.suppl_a.353.

Ceftazidime as a single agent in the management of children with fever and neutropenia.

J Antimicrob Chemother. 1983 Jul;12 Suppl A:347-51. doi: 10.1093/jac/12.suppl_a.347.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验